Subha Madhavan, a dynamic and results-driven leader, has taken on a new role as Vice President & Head of AI/ML, Quantitative & Digital Sciences, End-to-End Clinical Development at Pfizer. Subha has a strong track record of excellence in organizations that operate in the nexus of science, technology, and business. She is also a world-class leader in Oncology R&D, Precision Medicine, Digital Health, Data Science & Analytics, Bioinformatics, Product development, Clinical informatics and Health IT.
Prior roles include:
- Vice President & Head of Clinical AI/ML, Early Clinical Development – Pfizer
- Forum Leader and Speaker, AI and Machine Learning in Healthcare – HIMSS
- Head of Data Science, Oncology R&D – AstraZeneca
This topic has 0 replies, 1 voice, and was last updated 2 months, 2 weeks ago by Jackie Gilbert.
You must be logged in to reply to this topic.